[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100579569":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":30,"locations":36,"responsibleParty":55,"collaborators":25,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":25,"eligibilityCriteria":65,"healthyVolunteers":61,"sex":66,"minAge":67,"maxAge":68,"enrollmentInfo":69,"targetDuration":25,"studyType":72,"phases":73,"briefSummary":75,"conditions":76,"keywords":78,"overallStatus":83,"whyStopped":25,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"Sheikh Zayed Medical College","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Finesteride group","ACTIVE_COMPARATOR","Group A will receive topical finasteride spray 0.25% twice daily for 12 weeks",[13],"Drug: topical finasteride",{"label":15,"type":10,"description":16,"interventionNames":17},"Minoxidil group","Group B will receive topical 5% minoxidil twice daily for 12 weeks",[18],"Drug: Topical minoxidil",[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","topical finasteride","Group A will receive topical finesteride spray 0.25% twice daily for 12 weeks",[9],null,{"type":21,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Topical minoxidil","Group B will receive topical 5% minoxidal twice daily for 12 weeks",[15],[31],{"name":32,"role":33,"phone":34,"phoneExt":25,"email":35},"Farah Humera, post graduate resident derma","CONTACT","+923328334251","drfarahumera1@gmail.com",[37],{"facility":38,"status":25,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Sheikh zayed Medical College and Hospital, Rahim Yar Khan, Punjab 644200","Rahim Yar Khan","Punjab Province","644200","Pakistan","PK",{"type":45,"coordinates":46},"Point",[47,48],70.30345,28.41987,{"lat":48,"lon":47},[51],{"name":52,"role":33,"phone":53,"phoneExt":25,"email":54},"Sheikh zayed Medical college rahim yar khan punjab","+92689230168","info@szmc.edu.pk",{"type":56,"investigatorFullName":57,"investigatorTitle":58,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"PRINCIPAL_INVESTIGATOR","Farah Humera","Post Graduate Resident in Dermatology","100579569","phase-2-various-procedural-treatment-options-for-androgenetic-alopecia-100579569",false,"NCT06826001","Various Procedural Treatment Options for Androgenetic Alopecia","COMPARISON OF EFFICACY OF TOPICAL FINESTERIDE VERSUS TOPICAL MINOXIDAL IN TREATMENT OF ANDROGENETIC ALOPECIA","Inclusion Criteria:\n\n* Age: 20-50 years\n* Gender: Male\n* ANDROGENETIC ALOPECIA with AGA stage 2-6 Norwood-Hamilton -classification\n* Patients not taking any treatment in last 1 month\n\nExclusion Criteria:\n\n* Abrasion or abnormalities to the scalp\n* Hair transplant\n* Hypersensitivity\n* Recent history of local infections of the head\n* History of relevant significant disease active seborrheic dermatitis\n* Concurrent use of :\n* corticosteroids\n* anabolic steroids or over-the-counter 'hair restorers'\n* use of drugs with anti-androgenic properties within 6 months light or laser treatment of the scalp within the last 3 months.","MALE","20 Years","50 Years",{"count":70,"type":71},190,"ESTIMATED","INTERVENTIONAL",[74],"PHASE2","Androgenetic alopecia (AGA)is the most common form of alopecia. It predominantly affects males, but there has been a significant surge in female preponderance too, over the last decade Minoxidil belong to the anti-hypertensive class but it also affects the potassium channels present in vascular smooth muscles and hair follicles. This potassium channel activity may stimulate the microcirculation around the hair follicles and induces arteriolar vasodilation, thereby encouraging conditions conducive to hair growth Topical administration of finasteride offers the potential to reduce systemic effects related to its mechanism of action by preferentially inhibiting 5-a reductase in the scalp, as has been suggested in recent years so in this study we are going to compare efficacy of topical minoxidil versus topical finasteride in treatment of androgenetic alopecia",[77],"Androgenetic Alopecia",[79,80,81,82],"androgenetic alopecia","finasteride","minoxidil","hairloss","NOT_YET_RECRUITING","2025-02-07",{"date":86,"type":87},"2025-02-13","ACTUAL",{"date":89,"type":71},"2025-02",{"date":91,"type":71},"2025-07",{"name":5,"class":6},1]